Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 13, which means every article in Brain Disorders & Therapy has got 13 average citations.

Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Total published articles

40 62 58 46 13 13 11 16 24 72 42 17 7

Research, Review articles and Editorials

0 0 0 14 11 4 8 12 10 29 34 9 4

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 62 58 32 2 9 3 4 14 43 8 8 3

Conference proceedings

0 10 8 5 0 0 121 53 89 117 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

45 71 133 108 67 74 69 72 86 110 23 14 0
Journal total citations count 887
Journal h-index 13
Important citations

Perera N, Javeed M, Lyketsos CG, Leroi I. Neuropsychiatric aspects of dementia. InDementia 2017:79-86.

Khadijah B. Research & Reviews: Journal of Medical and Health Sciences.  

Kiran Mayee K. Emerging Trends in Neuropsychiatry.

Zasler ND, Aloisi M, Contrada M, Formisano R. Disorders of consciousness terminology: history, evolution and future directions. Brain injury. 20;9:1-6.

赵文波. 脊髓损伤后脑脊液在内源性神经干细胞增殖分化中作用的实验研究进展. 贵州医药. 2016 Nov 11(2016 年 09):992-4.

Danielski LG. Avaliação da neuroproteção da vitamina B6 na sepse experimental. Programa de Pós-Graduação em Ciência da Saúde. 2016.

Грабчак ОІ. Метаболізм рибофлавіну до його коферментних форм в тканинах щурів різного віку.

Huang H. Mass Spectrometry-Based Metabolomics: Platform Development and Application to Neurodegenerative Disease (Doctoral dissertation, University of Akron).

牛曼曼, 韩颖, 秦炯, 杜军保, 金红芳, 赵阳, 张静, 李沁芮. FMR1 基因前突变的临床表现和分子机制. 中华实用儿科临床杂志. 2016 Jan 11(2016 年 20):1588-90.

Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V. Síndrome de temblor y ataxia asociado al X frágil: presentación clínica, patología y tratamiento. revista de Neurología. 2019;199.

Srilatha B. A Review on Genetic Disorders and Syndromes. Biochem Mol Biol Lett. 2017;3(2):118.

El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Research Open. Journal of Molecular Genetics. 2018;1:1-4.

G Tan MM, S Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. Fragile X-associated neuropsychiatric disorders: a case report. Future Neurology. 2019:14.

Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, et al. Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome. Heliyon. 2019;5.

Akash R, Jasdeep S, Salcedo-Arellano M, Wilmar S, Xianlai D, Hagerman R. Fragile X syndrome and fragile X-associated disorders. F1000Research. 2017;6.

Wheeler AC, Miller S, Wylie A, Edwards A. Mindfulness and Acceptance as Potential Protective Factors for Mothers of Children With Fragile X Syndrome. Frontiers in public health. 2018;6:316.

Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. Presence of middle cerebellar peduncle sign in FMR1 premutation carriers without tremor and ataxia. Frontiers in neurology. 2018;9.

El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Fentanyl Overdose in a female with the FMR1 premutation and FXTAS. Journal of molecular genetics (Isleworth, London, England). 2018;1.

Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.

Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. General anesthetic use in fragile X Spectrum disorders. Journal of neurosurgical anesthesiology. 2019;31:285-90.